Health Condition 1: C719- Malignant neoplasm of brain, unspecified
Conditions
Interventions
Intervention1: Not Applicable: Not Applicable
Control Intervention1: Not Applicable: Not Applicable
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: 1. Morphology and histology confirmed diffuse gliomas of different WHO grades of II, III and IV, where sufficient tissue will be available for all components of the studies. 2. Karnofsky Performance Status should be more than or equal to 60. 3. Patients should be able to provide written informed consent for the collection and usage of the clinical samples for research purpose. 4. Both primary and recurrent tumors can be collected for research purpose.
Exclusion criteria
Exclusion criteria: 1. Patients, who are not able to provide written consent, should be excluded from the study. 2. Mixed CNS tumors or patients suffering from other cancers should be excluded. 3. Patients suffering from associated viral, bacterial, protozoan and fungal diseases should be excluded. 4. Patients with another neurological disorders/ organ failure should be excluded. Patients undergoing treatment for diseases other than specified CNS tumors should be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Not applicable; this is a biology exploratory studyTimepoint: Outcome will be assessed after the study completion | — |
Secondary
| Measure | Time frame |
|---|---|
| Not applicableTimepoint: Not applicable | — |
Countries
India
Contacts
Public ContactDr Epari Sridhar
Tata Memorial Hospital
Outcome results
None listed